Sugi Predict

Sugi Predict / Compounds / SCHEMBL15087802

SCHEMBL15087802

SCHEMBL15087802

CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNC(=O)Cc2ccc(-c3ccccc3)cc2)O[C@@](OCCCSCCNC(=O)c2ccc(-c3ccc(C(=O)NCCSCCCO[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)Cc5ccc(-c6ccccc6)cc5)O4)cc3)cc2)(C(=O)O)C[C@@H]1O

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CD22 P20273 10/20 0.79
▸ MAG P20916 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15087862 1.00 CD22 (0.79) CD22MAG
SCHEMBL15087696 0.97 CD22 (0.79) CD22MAG
SCHEMBL17538454 0.96 CD22 (0.76) CD22
SCHEMBL16373010 0.94 CD22 (0.88) CD22
SCHEMBL15087772 0.94 CD22 (0.88) CD22
SCHEMBL15087715 0.94 CD22 (0.72) CD22MAG
SCHEMBL16373043 0.94 CD22 (0.72) CD22MAG
SCHEMBL16373130 0.92 CD22 (0.79) CD22MAG
SCHEMBL16373016 0.92 CD22 (0.83) CD22
SCHEMBL16373044 0.92 CD22 (0.85) CD22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260467-B2 Sialic acid dimers BROSSMER REINHARD (DE) 2016-02-16 — — US disclosed
US-20150005245-A1 Sialic Acid Dimers BROSSMER REINHARD (DE) 2015-01-01 — — US disclosed
EP-2610263-A1 Sialic acid dimers Brossmer, Reinhard (DE) 2013-07-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005245-A1 Sialic Acid Dimers SIGLEC9, SIGLEC7, NEU2 CD22 20/4885MAG 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.